Resumption Of Funding Season Signals A Bullish Outlook
After a subdued summer period, Europe’s venture funding scene is witnessing a notable resurgence. In the first half of 2025 alone, 12 startups have achieved unicorn status—each boasting valuations surpassing $1 billion. Despite a decrease in mega-round frequency since 2021, investor fervor remains undiminished, with particular emphasis on sectors such as biotechnology, defense, and artificial intelligence.
Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram
Monthly Breakdown Of Unicorn Achievements
July 2025
Lovable – The Swedish AI startup Lovable, renowned for its innovative approach to vibe coding, ascended to unicorn status in record time. Just eight months post-launch, the company raised a $200 million Series A led by Accel, reaching a valuation of $1.8 billion. Notably, while Lovable Labs Inc. is incorporated in Delaware, its core team and talent acquisition are centered in Stockholm.
Fuse Energy – British renewable energy firm Fuse Energy, established in 2022 by former Revolut executives, secured a funding round that valued the enterprise at over $1 billion, as reported by The Times. This development underscores a burgeoning investor interest in sustainable innovations within the energy sector.
June 2025
Mubi – Film-streaming pioneer Mubi, which began as a curated platform in 2007, raised a $100 million round led by Sequoia Capital. This financing propelled its valuation to $1 billion, positioning it as a credible rival to streaming titans like Netflix, Amazon, and Disney. Mubi’s evolution into a film production and distribution powerhouse further solidifies its market standing.
Zama – The French startup Zama reached unicorn status after a $57 million Series B round pushed its valuation north of $1 billion. Specializing in homomorphic encryption, Zama leverages advanced cryptographic algorithms to ensure data security, reflecting growing investor confidence in the cybersecurity vertical.
Isar Aerospace – German space company Isar Aerospace became a unicorn in June following a convertible bond agreement with Eldridge Industries for €150 million (approximately $173 million). Spun off from the Technical University of Munich, the company exemplifies Europe’s increasing commitment to space and defense technology innovation.
May 2025
Tekever – Hailing from Portugal, dual-use drone startup Tekever confirmed its valuation of over £1 billion during a May funding round. The company, backed by distinguished investors including Ventura Capital and Baillie Gifford, is set to deploy £400 million in a U.K.-based development plan focused on AI-driven defense advancements.
Quantum Systems – German drone and AI technology leader Quantum Systems achieved unicorn status after raising €160 million in a Series C funding round. The capital will accelerate its global expansion and further development of autonomous drones, with major support from investors such as Balderton Capital and Airbus Defense and Space.
Parloa – Specializing in conversational AI for customer service, German startup Parloa reached a $1 billion valuation with a $120 million Series C round. This milestone, secured from Durable Capital Partners and General Catalyst among others, punctuates a rapid growth trajectory following earlier successful funding rounds.
March 2025
Isomorphic Labs – London-based Isomorphic Labs, an AI-driven drug discovery platform spun out of Google’s DeepMind, solidified its market position by raising $600 million in external funding. Led by Thrive Capital with contributions from GV and Alphabet, this significant injection of capital marks its entry into unicorn territory.
February 2025
Tines – Dublin’s Tines, renowned for its AI-powered workflow automation, crossed the unicorn threshold by securing $125 million in its Series C round at a $1.125 billion valuation. Originally rooted in security workflow automation, Tines’ solutions now extend across diverse areas within the tech ecosystem, powering billions of automated actions each week.
January 2025
Verdiva Bio – In less than a year since its inception, London-based biotech firm Verdiva Bio raised an impressive $410 million in its Series A, immediately elevating it to unicorn status. With a pipeline that includes an innovative oral-based GLP-1 drug similar to Ozempic and Wegovy, the company is poised to redefine healthcare outcomes.
Neko Health – Co-founded by Spotify’s Daniel Ek, Swedish startup Neko Health secured a $260 million Series B round at a valuation of $1.8 billion. The company’s preventative health platform, which leverages comprehensive body scans, aims to expand its operational footprint from Stockholm and London into the U.S. market while intensifying its research and development efforts.
Conclusion
The evolving landscape of European startups continues to invigorate the funding arena, with each unicorn emblematic of a strategic leap in technology and innovation. As investors channel capital into transformative sectors ranging from AI to biotech, the robust early performance of 2025 signals a promising trajectory for the continent’s entrepreneurial ecosystem.
